Notice ID: a1602d086831487bbe169f18a4820d96Solicitation
Acquisition of Nilotinib (Tasigna�) Capsules, or Equivalent
Archived on January 21, 2023. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 3:00 PM UTC−05:00
- Posted
- January 3, 2023
- Notice type
- Solicitation
- Set-aside
- Total Small Business Set-Aside (FAR 19.5)
- NAICS
- 325412: Pharmaceutical Preparation Manufacturing
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NIH NCI
- Last updated
- Sep 9, 2025
Identifiers
- Solicitation number
- 75N91023Q00019
- Notice ID
- a1602d086831487bbe169f18a4820d96
Description
The purpose of this amendment is to extend the submission deadline until January 6, 2023, 03:00 pm EST. This is a combined synopsis/solicitation for commercial items, prepared in accordance with the format in FAR 12.6 as supplemented with additional information included in this notice, and shall be processed in accordance with FAR subpart 13.5 - Simplified Acquisition Procedures for Certain Commercial Items. This announcement constitutes the only solicitation and a separate written solicitation will not be issued. This solicitation, 75N91023Q00019, is issued as a request for quote (RFQ) and includes all applicable provisions and clauses in effect through FAR Federal Acquisition Circular (FAC) 2022-08 (10-28-2022), simplified acquisition procedures for commercial items. The North American Industry Classification System code is 325412 and the business size standard is 1,250 employees. The Product or Service Code is category 6505 - Drugs and Biologicals. The anticipated award shall be a firm fixed price, indefinite delivery/indefinite quantity (IDIQ) type contract. The Government anticipates a single-award IDIQ. The period of performance of the resulting IDIQ award shall consist of a 4-year ordering period. Multiple delivery orders are anticipated during the 4-year ordering period. THIS IS A TOTAL SMALL BUSINESS SET-ASIDE. REFERENCE RFQ NO. 75N91023Q00019 (ATTACHED)
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75N91023Q00019- Solicitation
Award typically follows within 30–90 days after the response deadline. (estimate)
- 3×SolicitationCurrentDec 21, 2022
Acquisition of Nilotinib (Tasigna�) Capsules, or Equivalent
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N91023Q00019
Archive Date
Jan 21, 2023
Office Address
Bethesda, MD, 20892